Current and future therapeutic approaches to the common cold

Slides:



Advertisements
Similar presentations
Swine flu.
Advertisements

Chapter 28 HSC 4302 SPR08 A lesson for the 8 th grade student Kayla Shinneman, Amber Carney, Alicia McMahon, Takara Campbell, Robin Manzella HSC4302 Spring.
Nursing Care of Clients with Upper Respiratory Disorders.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 77 Drugs for Allergic Rhinitis, Cough, and Colds.
Drugs Affecting the Respiratory System
The Immune System The Body’s Defense.
Chapter 1 Introduction to the Scientific Method Can Science Cure the Common Cold?
Vitamins - what is the evidence? Rohan Subasinghe.
SORE THROAT & OTITIS MEDIA
By: Scott Panchik. Cold  Each year people in the United States suffer 1 billion colds!  Adults average 2-4 colds/year.  Cold symptoms include: runny.
Influenza (Flu)
HIV/AIDS Treating the Symptoms with Vitamins and Herbs MDyer_HW499-01_Unit 4 Assignment.
Rapivab™ - peramivir injection
Respiratory System PHARMACOLOGY
Bronchitis in children. Acute upper respiratory tract infections Prof. Pavlyshyn H.A., MD, PhD.
Bronchodilating Drugs Pat Woodbery, ARNP, CS Professor of Nursing.
PharmacologyPharmacology Drugs used to treat: Asthma Rhinitis & Cough Drugs used to treat: Asthma Rhinitis & Cough.
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
Winona H1N1 Control Plan Matt Dillon Patrick Keys Karsten Jepsen Allie Lyman.
Earth is full of microscopic invaders that can wage war in your body. Infectious diseases are caused by microorganisms; viruses, bacteria, fungi, protists,
Common Infectious Disease. Health Stats ) Pneumonia 1) Pneumonia 2) Tuberculosis 2) Tuberculosis 3) Infectious Diarrhea 3) Infectious Diarrhea.
Clinical Approach to the Diagnosis of SARS Joshua P. Metlay, MD, PhD VA Medical Center Division of General Internal Medicine Center for Clinical Epidemiology.
Upper Respiratory Tract Disorder Lecture 2 12/14/20151.
Rhinitis April 10, THE NOSE CT of THE NOSE.
1 Common cold. 2 Background Heikkinen T and Järvinen A. Lancet 2003;361:51–59. Viral cause : rhinoviruses 30–50%, coronaviruses 10–15%, influenza viruses.
1 Robert J. Spiegel, M.D. Sr. V. P. Medical Affairs Chief Medical Officer Schering Plough FDA ADVISORY COMMITTEE 5/11/01.
Quick Insights on Some Viral Issues Dr. Haya Al-Tawalah Clinical Virologist.
1. 2  Is used when referring to an URTI & is self- limited & caused by a virus (viral rhinituis).  nasal congestion, rhinorrhea, sneezing, sore throat.
Prescribing for patients with COPD Evidence Update Emma Blanden- Pharmacist.
Antibiotics in Addition to Systemic Corticosteroids for Acute Exacerbations of Chronic Obstructive Pulmonary Disease Johannes M.A. Daniels; Dominic snijders;
Important diseases and their global impact Objectives To be able to describe the causes and means of transmission of malaria, AIDS/HIV and T.B To be able.
Drugs for Allergic Rhinitis, Cough, and Colds. Allergic Rhinitis  Inflammatory disorder of the upper airway, lower airway, and eyes  Symptoms  Sneezing.
Myths about flu and the flu vaccine
Nursing Management: Upper Respiratory Problems
Drugs for Allergic Rhinitis, Cough, and Colds
VIRAL INFLUENZA.
Drugs for Upper Respiratory Disorders
Managing acute exacerbations of COPD in primary care.
Effects of Uric acid- lowering therapy on renal outcomes: a systematic review and meta-analysis Nephrol Dial Transplant (2014) 29: Vaughan Washco.
Kavita, Dinesh Kumar Sharma, Renu Vij, Jatinder Singh
2016 EAC Range NEW CHEWABLES!.
Avian Influenza A (H5N1) “Bird Flu”
Presentation on Viral flu
COMMON COLD (NASOPHARYNGITIS, RHINOPHARYNGITIS, viral rhinitis )
Bronchial Asthma Dr.Radhakrishna. S. A. Bronchial Asthma Dr.Radhakrishna. S. A.
Analysis of Safety and Efficacy of Dexmedetomidine as Adjunctive Therapy for Alcohol Withdrawal in ICU Vincent Rizzo MD MBA FACP Ricardo Lopez MD FCCP.
Fever and Antipyretic use in children Clinical report AAP 2011
Therapeutic & Toxic Potential of Over-the-Counter Agents
First time a CETP inhibitor shows reduction of serious CV events
Community pharmacy lecture no.4 respiratory system sore throat
Community Pharmacy Respiratory system Lecture 3.
How do your cells fight off invaders?
Lower respiratory infections
Community pharmacy lecture no.5 respiratory system rhinitis
Figure 19.1 Alzheimer disease and the resulting dementia occur when changes in the brain hamper neurotransmission.
Bronchiolitis Clinical Practice Guideline QI Project
Introduction to Clinical Pharmacology Chapter 9 Antibacterial Drugs That Interfere With DNA/RNA Synthesis.
Disorders of the Respiratory System
Antihistamines and Nasal Decongestants
Severe Acute Respiratory Syndrome (SARS)
Viruses.
Common Cold The common cold comprises a mixture of viral upper respiratory tract infections. It is self-limiting. over-the-counter (OTC) medicines for.
Upper Respiratory Tract Infections
Drugs Affecting the Respiratory System
Cholinesterase Inhibitors: Actions and Uses
CHAPTER 40 THE IMMUNE SYSTEM AND DISEASE
Viruses.
Microbial Biotechnology
The following slides highlight a report on a presentation at the American College of Cardiology 2004, Scientific Sessions, in New Orleans, Louisiana on.
Presentation transcript:

Current and future therapeutic approaches to the common cold Exper. Rev.2003 R2 손재돈

Pathophysiology Rhinovirus : most common Transmission : hand contact, aerosol Hypothesis Cooling  upper airway vasoconstriction Inhibition defenses converting viral colonization Symtom is Host inflammatory response Develop 1~2 days, Peak 2~4 days Nasal obstruction/rhinorrhea/sore throat Malaise/headache/ low-grade fever 2~3 wks

Epidemiology Most common Acute illness in all ages Increase in medical resource Risk factors Stress/Day-care in preschool/smoking Protective factors Red wine/Day-care in early school Frequent cold in 2~3 ages Likely to 6/8/11/13 ages

Current diagnostic approaches Based on symtoms Recent study, assessing Common cold No definite predictive criteria Rhinovirus DNA in Nasal swab Useless in daily ER or Primary office

Current therapeutic approaches 1. Overview Common cold : medically important But, Cure is not very successful Misconception/Misprescription Many antiviral agents are few benefit Combine antiviral & anti-inflammatory Improve outcome Maximum benefit early Dx. & Tx.

3. Anticholinergics agents 2. Decongestants α-adrenergic agonist Pseudoephedrine(액티피드) /Phenylpropanolamine Nasal obstruction/rhinorrhea No evidence benefit after several days 3. Anticholinergics agents Ipratropium( atrovent, inhalation) Rhinorrhea/sneezing

4. Antihistamines 5. Cough medicines 1st Antihistamines, chlorpheniramine 페니라민 Sneezing. Rhinorrhea, cough 2nd, Antihistamines, loratadine 클라리틴 only histamine receptor affect Not pass BBB 5. Cough medicines Mucolytics : modest beneficial 이외에는 similar to placebo

6. Mast cell stabilizes 7. NSAID Sodium cromoglycate(클레신) inhibit ICAM-1 ICAM-1, receptor for rhinovirus No benefit in RCT 7. NSAID Ibuprofen(캐롤) Headache/sneezing/myalgia and cough Combination other drugs : more effect

8. Steam inhalation 9. Vitamin C Symptom relief, but no reduction shedding 9. Vitamin C Controversy Recommend : 100mg daily intake A study, 500mg*2/day in winter Significant reduction in the number of cold Faster recovery But, fail to duplicated in large group

10. Zinc 11. Echinacea Controversy similar to Vit.C called the Purple coneflowers popularly boost immune system in america 16 study, better than placebo

12. Antibiotics 13. Steroids Most patients want to antiBiotics ‘Probably effective but not routinely recommended’ Amoxicillin(오그멘틴)/azithromycin(지스로맥스)/erythromycin(에릭) No evidence benefit in placebo test 13. Steroids Not effective in common cold

14. Antiviral agents 241 studies, interferon and other agents No licensed effective for common cold Pleconaril, inhibit viral uncoating In RCT, 1 day reduction to placebo Symptom reduction 20% to placebo But, antiviral agents developing

15. Multivitamins & minerals Daily Vit. E & multivitamine-mineral diet in well-nourished people No favorable effect in Acute URI Another study in DM people Significantly fewer infection Subclinical deficiency in DM individuals

Vaccine development Ultimate goal Hampered factors Large variety of virus High rate of re-infection despite antigenic variation Extensive variability in viral coat proteins Variable efficacy in immunity state Potential pathogenicity in neonates

Optimal therapy Educating patients about illness Targeting most distress symptom Adequate rest/humidity/take warm fluid/ well-diet/elevate head of bed α-adrenergic agonist/anticholinergics/antihistamine Nasal obstruction/rhinorrhea NSAIDS or AAP : treat systemic symptom Vit C/Zinc/echinacea : controversial Antibiotics : No role in common cold Pleconaril : close to achive, not yet Multivitamine : In diabetes

Phamacoeconomics 20 million days missed works 22million days missed school 25$ billion dollars 25 million office visits/years

Factors likely to affect choice of therapy 1. Patient compliance Recurrent/several times daily > difficult Clinical environment less compliance compare to study 2. Drug interactions & adverse effects Decongestants poorly controlled hypertention -> Phenylopropanolamine take off d/t hemorrhagic stroke incidence raise Rebound nasal congestants

1st antihistamines NSAID Warm stream Vit C Zinc Echinacea Pleconaril Confusion Affect CNS system NSAID Renal impairment/GI bleeding/Aseptic meningitis Warm stream Burns/microrganism Vit C Diarrhea Zinc Nausea & 식욕저하 Echinacea Anaphylaxis Pleconaril GI disturbance/menstrual irregularity

Conclusions Symptomatic measures -> current mainstay Specific antiviral agent : not available Zinc/Vit C/echinacea : controversial Any agent start as soons as onset

Prescription 액티피드 클라리틴 캐롤 Betadine 가글